These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8057059)

  • 1. Depression treatment.
    Goldstein AO; Ives TJ
    J Fam Pract; 1994 Aug; 39(2):114, 116. PubMed ID: 8057059
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressant use among elderly patients.
    Flint A; Silveira J
    Am J Psychiatry; 2001 Feb; 158(2):328-30. PubMed ID: 11156834
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of depression: the implications for managed care--roundtable discussion: Part 2.
    Arikian S; Casciano J; Kang-Cipolla L; Vodoor M; Grubin M; Clark D; Waugh W; Kelsey J; Osborn LW
    Manag Care Interface; 2000; Suppl B():19-25, 32. PubMed ID: 11183021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression in the workplace: negative effects, perspective on drug costs and benefit solutions.
    Riotto M
    Benefits Q; 2001; 17(2):37-48. PubMed ID: 11372474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of clinical efficacy.
    Ferrier IN
    Br J Psychiatry Suppl; 1993 Jul; (20):25-8. PubMed ID: 8352913
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in Taiwan.
    Su KP; Tang CH; Chang HC; Chiu WC; Lu N; Huang KC
    Int Clin Psychopharmacol; 2019 Jul; 34(4):170-178. PubMed ID: 30964763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effective treatment of depression with selective serotonin reuptake inhibitors.
    Panzarino PJ; Nash DB
    Am J Manag Care; 2001 Feb; 7(2):173-84. PubMed ID: 11216334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer antidepressants for the treatment of depression in adults.
    Hatcher S; Arroll B
    BMJ; 2012 Jan; 344():d8300. PubMed ID: 22262785
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of major depressive disorder in children and adolescents.
    Ramchandani P
    BMJ; 2004 Jan; 328(7430):3-4. PubMed ID: 14703522
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased use of antidepressants in Wuhan, China: a retrospective study from 2006 to 2012.
    Gao P; Zhang H; Xu H; Zhang C; Liu D
    Medicina (Kaunas); 2013; 49(12):529-34. PubMed ID: 24858993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug selection. Old versus new.
    Mant A
    Aust Fam Physician; 1999 Oct; 28(10):1036-8. PubMed ID: 10592582
    [No Abstract]   [Full Text] [Related]  

  • 13. SSRIs vs tricyclic antidepressants.
    Griffin GH
    J Fam Pract; 1996 Feb; 42(2):110. PubMed ID: 8606296
    [No Abstract]   [Full Text] [Related]  

  • 14. One-year costs of second-line therapies for depression.
    Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of depression: the implications for managed care--roundtable discussion: Part 3.
    Vodoor M; Southwell YP; Grubin M; Wert S; Kang-Cipolla L; Denes A; Evans S; Mason J; Zarr M; Osborn L; Kenney J; Hunkeler E; Waugh W; Bull S
    Manag Care Interface; 2000; Suppl B():26-32. PubMed ID: 11183022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders.
    Stein MB; Cantrell CR; Sokol MC; Eaddy MT; Shah MB
    Psychiatr Serv; 2006 May; 57(5):673-80. PubMed ID: 16675762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaco-economic aspects of antidepressants and antipsychotic drugs].
    Laux G
    Psychiatr Prax; 2003 May; 30 Suppl 2():S90-3. PubMed ID: 14509049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of antidepressive agents: a systematic critique of experimental and observational studies.
    Barbui C; Percudani M; Hotopf M
    J Clin Psychopharmacol; 2003 Apr; 23(2):145-54. PubMed ID: 12640216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis.
    Sclar DA; Skaer TL; Robison LM; Galin RS; Legg RF; Nemec NL
    J Clin Psychiatry; 1998; 59 Suppl 2():13-7. PubMed ID: 9559755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
    Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
    Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.